Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andrea L.A. Wong"'
Autor:
Robert John Walsh, Rebecca Ong, Seng Wee Cheo, Peter Q.J. Low, Aishwarya Jayagopal, Matilda Lee, Natalie Ngoi, Samuel G. Ow, Andrea L.A. Wong, Siew Eng Lim, Yi Wan Lim, Valerie Heong, Raghav Sundar, Ross A. Soo, Cheng Ean Chee, Wei Peng Yong, Boon Cher Goh, Soo Chin Lee, David S.P. Tan, Joline S.J. Lim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionMolecular profiling of metastatic breast cancer (MBC) through the widespread use of next-generation sequencing (NGS) has highlighted actionable mutations and driven trials of targeted therapy matched to tumour molecular profiles, with imp
Externí odkaz:
https://doaj.org/article/98dbdbab3f7349b688320adc069900de
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Purpose:RET is an estrogen response gene with preclinical studies demonstrating cross-talk between the RET and estrogen receptor (ER) pathways. We investigate the role of lenvatinib, a multikinase inhibitor with potent activity against RET, in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e493f677e970d70092bf8afa81bf17c
https://doi.org/10.1158/1078-0432.c.6532424.v1
https://doi.org/10.1158/1078-0432.c.6532424.v1
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Supplementary Table from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02061fae97a0b8e77fb74d487409f1d
https://doi.org/10.1158/1078-0432.22486937
https://doi.org/10.1158/1078-0432.22486937
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Supplementary Data from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e00fc277da44ab4288b38054c7a7e0c6
https://doi.org/10.1158/1078-0432.22486946
https://doi.org/10.1158/1078-0432.22486946
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Supplementary Figure from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51301d328c110373e6f3c2828ea93958
https://doi.org/10.1158/1078-0432.22486943
https://doi.org/10.1158/1078-0432.22486943
Autor:
Joline S.J. Lim, Andrea L.A. Wong, Samuel G.W. Ow, Natalie Y.L. Ngoi, Gloria H.J. Chan, Yvonne L.E. Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda Lee, Joan R.E. Choo, Hon Lyn Tan, Wei Peng Yong, Ross A. Soo, David S.P. Tan, Cheng Ean Chee, Raghav Sundar, Kritika Yadav, Supriya Jain, Lingzhi Wang, Bee Choo Tai, Boon Cher Goh, Soo-Chin Lee
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(11)
Purpose: RET is an estrogen response gene with preclinical studies demonstrating cross-talk between the RET and estrogen receptor (ER) pathways. We investigate the role of lenvatinib, a multikinase inhibitor with potent activity against RET, in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e25c9b984006e2599309262484b22b37
https://pubmed.ncbi.nlm.nih.gov/35363275
https://pubmed.ncbi.nlm.nih.gov/35363275